Founders Capital Management Abbott Laboratories Transaction History

Founders Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$100.73 - $112.44 $20,146 - $22,488	-200 Reduced 28.57%	500 $51,000
Q1 2024 Apr 10, 2024	SELL	$109.52 - $120.96 $5,256 - $5,806	-48 Reduced 6.42%	700 $79,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $31,047 - $37,251	-325 Reduced 30.29%	748 $72,000
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $9,492 - $11,473	93 Added 9.49%	1,073 $117,000
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $32,664 - $36,136	280 Added 40.0%	980 $116,000
Q4 2019 Jan 24, 2020	BUY	$78.51 - $87.4 $3,925 - $4,370	50 Added 7.69%	700 $61,000
Q2 2019 Jul 11, 2019	BUY	$72.88 - $85.0 $3,644 - $4,250	50 Added 8.33%	650 $55,000
Q4 2017 Jan 22, 2018	SELL	$53.68 - $57.47 $16,104 - $17,241	-300 Reduced 33.33%	600 $34,000
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $43,254 - $48,276	900	900 $48,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management with notifications on news.